Specific antibody response to oligomannosidic epitopes in Crohn's disease

Clinical and Diagnostic Laboratory Immunology

Volumn 3, Issue 2, 1996, Pages 219-226

  Sendid, B ^a   Colombel, J F ^a   Jacquinot, P M ^b   Faille, C ^c   Fruit, J ^a   Cortot, A ^a   Lucidarme, D ^a   Camus, D ^a,b   Poulain, D ^a,b,d  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Inst Natl S la Rech Med U 42   (France)

^c CEMAGREF   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; PHOSPHOPEPTIDOMANNAN; UNCLASSIFIED DRUG;

ADULT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GAS LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; ULCERATIVE COLITIS;

EID: 0029883566     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.3.2.219-226.1996     Document Type: Article

References (18)

1. Barclay, G. R., H. McKenzie, J. Pennington, D. Parratt, and C. R. Pennington. 1992. The effect of dietary yeast on the activity of stable chronic Crohn's disease. Scand. J. Gastroenterol. 27:196-200.
2. Barnes, R. M. R., S. Allan, C. H. Taylor Robinson, R. Finn, and P. M. Johnson. 1990. Serum antibodies reactive with Saccharomyces cerevisie in inflammatory bowel disease: is IgA a marker for Crohn's disease? Int. Arch. Allergy. Appl. Immunol. 92:9-15.
3. Best, W. R., J. M. Becktel, J. W. Singleton, and F. Kern. 1976. Development of a Crohn's disease activity index. Gastroenterology 70:439-444.
4. Bridget, T., A. Susan, and R. M. R. Barnes. 1991. Identification of a 200 kDa glycoprotein antigen of Saccharomyces cerevisiae. Immunol. Lett. 28:181-186.
5. Byron, J. K., K. V. Clemons, J. H. McCusker, R.W. Davis, and D. A. Stevens. 1995. Pathogenicity of Saccharomyces cerevisiae in complement factor five-deficient mice. Infect. Immun. 63:478-485.
6. Dubois, M., K. A. Gilles, J. K. Hamilton, P. A. Reber, and F. Smith. 1956. Colorimetric method for determination of sugars and related substances. Anal. Chem. 28:350-356.
7. Faille, C., D. W. R. Mackenzie, J. C. Michalski, and D. Poulain. 1992. Evaluation of an enzyme immunoassay using neoglycolipids constructed from Candida albicans oligomannosides to define specificity of anti-mannan antibodies. Eur. J. Clin. Microbiol. Infect. Dis. 11:438-446.
8. Fournet, B., G. Strecker, V. Leroy, and J. Montreuil. 1981. Gas liquid chromatography and mass spectrometry of methylated and acetylated methyl glycosides. Application to the structural analysis of glycoprotein glycans. Anal. Biochem. 116:489-502.
9. Frosch, M., I. Görgen, G. J. Boulnois, K. N. Timmis, and D. Bitter-Suermann. 1985. NZB mouse system for production of monoclonal antibodies to weak bacterial antigens: isolation of an IgG antibody to the polysaccharide capsules of Escherichia coli K1 and group B meningococci. Proc. Natl. Acad. Sci. USA 82:1194-1198.
10. Fukazawa, Y. 1989. Antigenic structure of Candida albicans: immunochemical basis of the serologic specificity of the mannans in yeast, p. 37-62. In E. Kurstak (ed.), Immunology of fungal diseases. Marcel Dekker Inc., New York.
11. Giaffer, M. H., A. Clark, and C. D. Holdsworth. 1992. Antibody to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance. Gut 33:1071-1075.
12. Hamada, T., F. Noda, and K. Hayashi. 1984. Structure of cell wall and extracellular mannans from Saccharomyces rouxii and their relationship to a high concentration of NaCl in the growth medium. Appl. Environ. Microbiol. 48:708-712.
13. Hayette, M. P., G. Strecker, C. Faille, D. Dive, D. Camus, D. W. R. Mackenzie, and D. Poulain. 1992. Presence of human antibodies reacting with Candida albicans O-linked oligomannosides revealed by using an enzyme-linked immunosorbent assay and neoglycolipids. J. Clin. Microbiol. 30:411-417.
14. Hearn, V. M., E. V. Wilson, J. P. Latge, and D. W. R. Mackenzie. 1990. Immunochemical studies of Aspergillus fumgigatus mycelial antigens by polyacrylamide gel electrophoresis and western blotting techniques. J. Gen. Microbiol. 136:1525-1535.
15. Hollander, D., C. M. Valdheim, E. Brettholz, G. M. Petersen, T. Delahunty, and J. I. Rotter. 1986. Increased intestinal permeability in patients with Crohn's disease and their healthy relatives - a possible etiologic factor. Ann. Intern. Med. 105:883-885.
16. Jewell, D. P., and J. A. Snook. 1990. Immunology of ulcerative colitis and Crohn's disease, p. 127-146. In R. N. Allan, M. B. R. Keighley, J. Alexander-Williams, and C. Hawkins (ed.). Flammatory bowel diseases. Churchill Livingstone, Edinburgh.
17. Kikuchi, S., A. Ohinata, Y. Tsumuraya, Y. Hashimoto, Y. Kaneko, and H. Matsushima. 1993. Production and characterization of antibodies to the β-(1→6)-galactotetraosyl group and their interaction with arabinogalactan-proteins. Planta 190:525-535.
18. Kocourek, J., and C. E. Ballou. 1969. Method for fingerprinting yeast cell wall mannans. J. Bacteriol. 100:1175-1181.